Keeping the tip of the GLP spear sharp: SQA 2016
Remaining on the forefront of FDA requirements and learning from our peers’ experience is why we invest in the SQA Conference every year including SQA 2016.
As of November 30, 2023 T3 Labs is Part of Veranex. Click Here to learn more.
GCMI Design & Development has moved to gcmiatl.org
Remaining on the forefront of FDA requirements and learning from our peers’ experience is why we invest in the SQA Conference every year including SQA 2016.
“At the preclinical stage of medical device product development, there is an important opportunity to identify and implement significant improvements before first clinical use. T3 Labs provides extensive expertise and capabilities in the critical preclinical stage of medical device product development.” – Jason White, Senior Director of Product Development, St. Jude Medical The challenge:…
ALung Technologies needed a CRO with great flexibility and responsiveness in order to maximize limited resources and accelerate the timeline associated with preclinical trials. “T3’s recommendation has accelerated our product refinement testing and preclinical trials saving ALung time and money at every step along the way.” – Jeremy Kimmel, PhD Director of New Technology for ALung Technologies…
Preclinical medical device testing: how do you know you are ready and how do you make the most efficient investment in preclinical?
Surefire Medical achieves FDA 510(k) clearance for direct-to-tumor embolization device Surefire Precision in just 76 days with the help of T3 Labs.